Most founders can produce a use-of-funds table. Fewer can explain why that allocation should make the company more valuable, more financeable, or less risky within a defined period. That is the difference investors are looking for.
A credible capital ask is not just "R10 million for sales, product, and working capital." It is a plan that shows how each rand changes the operating position of the business.
Start with the investment case, not the spreadsheet
The use of funds should answer a strategic question: what becomes true after this capital is deployed that is not true today? The answer might be increased production capacity, stronger margins, a larger contracted pipeline, regulatory readiness, market entry, or a more defensible technology platform.
If the allocation does not change the risk profile or growth profile of the company, investors will treat it as general funding pressure rather than growth capital.
Separate survival capital from growth capital
There is nothing wrong with needing working capital. Many good South African businesses are constrained by payment cycles, inventory needs, seasonality, or contract delivery timing. The mistake is presenting working capital as if it is automatically growth capital.
Be direct. If part of the raise stabilises operations, say so. Then explain what that stability unlocks: faster delivery, reduced supplier pressure, ability to accept larger orders, or improved gross margin. Investors prefer honest classification to polished vagueness.
Build the milestone bridge
A strong use-of-funds plan should connect allocation, action, evidence, and result. For example:
- Allocation: R2 million for sales team expansion
- Action: Hire two account executives and one sales operations lead
- Evidence: Existing pipeline, conversion rates, average contract value, and sales cycle length
- Result: Targeted contracted revenue, improved pipeline conversion, and clearer repeatability within 12 months
This bridge turns a budget line into an investor conversation. It gives the funder something to test, monitor, and believe.
Match the instrument to the milestone
Not every use of funds should be financed the same way. Asset purchases with predictable cash flows may fit debt better than equity. Market expansion with uncertain timing may need patient equity or quasi-equity. Development finance may suit job creation, localisation, productive capacity, or transformation-linked investment, but only if the documentation can support the claim.
The capital structure should follow the risk profile of the use of funds. When that link is missing, investors worry that the founder is asking for the wrong kind of money.
Show what happens if the full amount is not raised
Investors often ask what happens at a smaller cheque size. A strong founder can explain the minimum viable raise, the preferred raise, and the stretch raise. Each scenario should have a different deployment plan and a different milestone set.
This shows discipline. It also helps the founder avoid accepting a partial raise that is too small to achieve the promised outcome.
Keep the table simple, make the logic rigorous
The actual table can be simple: category, amount, percentage of raise, timing, and milestone. The work sits underneath it. The founder must be able to defend the assumptions, sequencing, and expected impact.
Investors do not fund categories. They fund evidence-backed milestones that make the next version of the business more valuable or less risky.
The bottom line
A use-of-funds page should never feel like a shopping list. It should read like an execution plan. When the capital ask is connected to milestones, the investor can see why the amount matters, why the timing matters, and why the founder is ready to deploy responsibly.